First National Bank of Omaha reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 41.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,734 shares of the healthcare conglomerate’s stock after selling 3,412 shares during the period. First National Bank of Omaha’s holdings in UnitedHealth Group were worth $877,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also made changes to their positions in the stock. State Street Corp raised its stake in shares of UnitedHealth Group by 2.5% in the first quarter. State Street Corp now owns 45,724,509 shares of the healthcare conglomerate’s stock worth $7,499,276,000 after buying an additional 1,122,534 shares during the last quarter. Dodge & Cox purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $1,658,560,000. Norges Bank bought a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. Legal & General Group Plc raised its stake in shares of UnitedHealth Group by 5.4% in the first quarter. Legal & General Group Plc now owns 4,954,692 shares of the healthcare conglomerate’s stock worth $812,630,000 after buying an additional 254,545 shares in the last quarter. Finally, Harris Associates L P raised its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Harris Associates L P now owns 4,646,307 shares of the healthcare conglomerate’s stock worth $762,041,000 after buying an additional 14,489 shares in the last quarter. 86.21% of the stock is currently owned by institutional investors.
Shares of UnitedHealth Group Incorporated (NYSE UNH) opened at 190.82 on Friday. The company’s 50 day moving average is $190.49 and its 200 day moving average is $175.87. UnitedHealth Group Incorporated has a 12 month low of $132.39 and a 12 month high of $196.04. The company has a market cap of $184.50 billion, a P/E ratio of 22.92 and a beta of 0.64.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Stockholders of record on Friday, September 8th will be paid a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.57%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
COPYRIGHT VIOLATION NOTICE: “UnitedHealth Group Incorporated (NYSE:UNH) Position Decreased by First National Bank of Omaha” was originally published by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another website, it was stolen and republished in violation of US and international copyright laws. The legal version of this report can be viewed at https://www.com-unik.info/2017/08/19/unitedhealth-group-incorporated-nyseunh-shares-sold-by-first-national-bank-of-omaha-updated-updated.html.
A number of analysts have commented on the company. Jefferies Group LLC reissued a “buy” rating and set a $192.00 price objective on shares of UnitedHealth Group in a report on Friday, May 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $205.00 target price (up from $200.00) on shares of UnitedHealth Group in a report on Saturday, April 22nd. Vetr lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $179.00 target price for the company. in a report on Monday, April 24th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $201.00 target price for the company in a report on Wednesday, June 7th. Finally, Barclays PLC upped their price objective on UnitedHealth Group from $200.00 to $217.00 and gave the company an “overweight” rating in a research note on Wednesday, July 19th. One investment analyst has rated the stock with a hold rating and twenty-four have issued a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of “Buy” and an average price target of $203.41.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the company’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total value of $990,219.60. Following the transaction, the director now directly owns 60,516 shares in the company, valued at approximately $10,816,629.84. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $182.64, for a total transaction of $913,200.00. Following the completion of the transaction, the director now owns 75,735 shares in the company, valued at $13,832,240.40. The disclosure for this sale can be found here. Over the last three months, insiders sold 15,540 shares of company stock worth $2,873,320. 0.89% of the stock is owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
What are top analysts saying about UnitedHealth Group Incorporated? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group Incorporated and related companies.